Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 23.39
(0.39%)
CNY 23.39
(0.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.46 Billion CNY | 46.77% |
| 2022 | -6.51 Billion CNY | -7.16% |
| 2021 | -6.07 Billion CNY | -198.99% |
| 2020 | -2.03 Billion CNY | -3379.88% |
| 2019 | -58.43 Million CNY | -11.19% |
| 2018 | -52.55 Million CNY | -139.88% |
| 2017 | -21.9 Million CNY | -357.6% |
| 2016 | -4.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.83 Billion CNY | 18.22% |
| 2024 Q2 | -2.42 Billion CNY | 14.46% |
| 2024 Q3 | -2.67 Billion CNY | -8.11% |
| 2023 Q1 | -5.67 Billion CNY | 12.95% |
| 2023 FY | -3.46 Billion CNY | 46.77% |
| 2023 Q4 | -3.46 Billion CNY | 19.35% |
| 2023 Q3 | -4.29 Billion CNY | 12.52% |
| 2023 Q2 | -4.91 Billion CNY | 13.33% |
| 2022 Q2 | -7.09 Billion CNY | 4.55% |
| 2022 Q1 | -7.43 Billion CNY | -22.27% |
| 2022 FY | -6.51 Billion CNY | -7.16% |
| 2022 Q4 | -6.51 Billion CNY | 6.95% |
| 2022 Q3 | -7 Billion CNY | 1.32% |
| 2021 Q1 | -3.02 Billion CNY | -48.15% |
| 2021 FY | -6.07 Billion CNY | -198.99% |
| 2021 Q2 | -3.37 Billion CNY | -11.65% |
| 2021 Q3 | -5.03 Billion CNY | -49.46% |
| 2021 Q4 | -6.07 Billion CNY | -20.63% |
| 2020 Q4 | -2.03 Billion CNY | -264.75% |
| 2020 FY | -2.03 Billion CNY | -3379.88% |
| 2020 Q3 | -558.89 Million CNY | -40.24% |
| 2020 Q2 | -398.53 Million CNY | -28.82% |
| 2020 Q1 | -309.38 Million CNY | -429.47% |
| 2019 Q3 | -40.66 Million CNY | -149.68% |
| 2019 Q4 | -58.43 Million CNY | -43.71% |
| 2019 Q2 | -16.28 Million CNY | -115.88% |
| 2019 Q1 | 102.55 Million CNY | 295.15% |
| 2019 FY | -58.43 Million CNY | -11.19% |
| 2018 FY | -52.55 Million CNY | -139.88% |
| 2018 Q4 | -52.55 Million CNY | 0.0% |
| 2017 FY | -21.9 Million CNY | -357.6% |
| 2016 FY | -4.78 Million CNY | 0.0% |